Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …

Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require a combination of surgery and chemotherapy for optimal …

Expected benefits of disruptive technologies such as self-driving vehicles may only
materialize if they are publicly accepted. Acceptance increases when implementation is …

Importance Randomized clinical trials have found that, in patients with advanced-stage
epithelial ovarian cancer, neoadjuvant chemotherapy has similar long-term survival and …

Background: Observational studies using traditional research designs suggest that influenza
vaccination reduces hospitalizations and mortality among elderly persons. Accordingly …

Objective Endometrial cancer uncommonly presents at an advanced stage and little
prospective evidence exists to guide the management thereof. We aimed to summarize the …

Objective To assess the potential cost-effectiveness of prehabilitation in medically frail
patients undergoing surgery for epithelial ovarian cancer (EOC). Methods We created a cost …

Objective In previous studies, neoadjuvant chemotherapy followed by interval debulking
surgery was not inferior to primary cytoreductive surgery as initial treatment for advanced …

Background: Cisplatin (CDDP) is widely used in treatment of cancer, yet patients often
develop resistance with consequent therapeutical failure. In CDDP-resistant cells alterations …

Background Primary cytoreduction followed by platinum-based chemotherapy is the primary
treatment for advanced ovarian cancer. However, neoadjuvant chemotherapy followed by …